Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders. - Wikidata - awgldk - TriplyDB

Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.

Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.

http://www.wikidata.org/entity/Q42428990

about

Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced delivery A Unilateral Cervical Spinal Cord Contusion Injury Model in Non-Human Primates (Macaca mulatta).Rapid inverse planning for pressure-driven drug infusions in the brain Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow Guided delivery of adeno-associated viral vectors into the primate brain Real-time MR imaging with Gadoteridol predicts distribution of transgenes after convection-enhanced delivery of AAV2 vectors Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system.Interventional MRI-guided putaminal delivery of AAV2-GDNF for a planned clinical trial in Parkinson's disease Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten disease.Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.Genetic therapy for the nervous system.Gene therapy for the neurological manifestations in lysosomal storage disorders.Optogenetic Approaches for Controlling Seizure Activity.Anterograde axonal transport of AAV2-GDNF in rat basal ganglia Imaging of Convective Drug Delivery in the Nervous System.MR-guided delivery of AAV2-BDNF into the entorhinal cortex of non-human primates.

P2860

Q26851517-14ABD387-DB0A-4AC7-83E6-99096ADBF7D1 Q27307173-45CA26FD-2796-4199-AA9F-A4DF69C62141 Q28486200-1FB2F1A2-CD37-4A5C-BBF0-4F83AF60E3E7 Q30523995-3F1853F9-C618-49A9-A79E-E83C7F3F6550 Q34061373-1A347F78-0655-40FA-83A4-66F4F845238A Q34080874-15AF479F-E351-4E6D-A83E-EF92F5594500 Q34087812-5B0819BF-FADD-41A9-BC1C-D8876F3E887E Q35086686-DFFA2FFA-0E62-411F-A11E-FE5B37DC2C7D Q35174910-0EE7C2CC-BED1-472A-9F19-0138C4261CCE Q36147515-F3B30B81-9594-45DE-89B8-E84A8005F4E1 Q36299764-4FFFCDB1-D11C-4A12-9EDC-A30688B1BD83 Q37127238-25FA8BCF-DD3A-4095-8291-DD933B57482E Q37856565-85EE236B-CE72-4B4F-BC35-50BC307DB38B Q38200599-0EA09FDD-F669-455A-800F-0B01B07080C6 Q38834011-69D9D117-5DEE-409B-8BED-EB667266D388 Q39628466-E2C324F2-5576-4C65-8198-6A7724552B7A Q50059251-DF6014AB-321A-4676-AAFB-6108F74CA52E Q52356936-4FAC0121-363F-4A0A-A406-D22A63264860

P2860

Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders.

http://www.wikidata.org/entity/Q42428990

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@en

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@nl

type

label

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@en

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@nl

prefLabel

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@en

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@nl

P1433

Q42428990-BE1413D1-3B8C-4EAC-AFB3-FFF2CE906DF2

P1476

Q42428990-71AA4E61-D6F2-4014-A680-C1C43569D53A

P2093

Q42428990-10831139-B569-4DD1-90C7-51681F7A7B15

Q42428990-18FCB616-49AE-441F-8DB6-0D4FC2C135D8

Q42428990-1D3C32B3-7A48-4257-AEB1-1BAAEE122F4F

Q42428990-34C99969-A53E-4F7D-AF5E-22D0B768D223

Q42428990-5049C9EB-B2C4-4D61-936E-2B240096DFC5

Q42428990-62780BE6-0164-4A12-BCC8-97881D18DA8F

Q42428990-89D8CBEC-0772-4574-B98C-7A13687C4A3D

Q42428990-8DF123BD-8995-4AED-9783-8DE51338B1A2

Q42428990-A83BB4D6-78D3-4EF4-A4F9-0187ACC68765

Q42428990-B6578F0D-CEB5-484B-B82D-CA9921581D42

P2860

Q42428990-15F38F43-BB61-4133-8D7A-106555194E13

Q42428990-182D6531-C3E8-4939-B0BD-276C7B4530F5

Q42428990-1B71F245-DC67-4884-80E8-2AC7DD2E603F

Q42428990-1B9E859A-5336-4781-8A0E-DA50F95B6251

Q42428990-22BAE842-A41C-46AB-845C-616A28DF2626

Q42428990-230E6E55-B086-4873-A238-31803E344072

Q42428990-33D3AF09-4C27-40E7-B26B-000A4D3D111D

Q42428990-35820E6C-7E7B-482A-9811-4F23A32C4C59

Q42428990-3C1054F6-A546-4BA7-8941-9ED253F64564

Q42428990-3D3D39D4-FEF1-4A9D-97E4-3684DAB7F02A

P304

Q42428990-A1B20809-ECEA-472A-BE0C-0E1F202DC6BF

P31

Q42428990-6B479A86-505E-4D8D-B9B9-1F8033FFC698

P356

Q42428990-A3CED6BB-405F-42F5-B1EA-58E918DCFE77

P433

Q42428990-6C1815AE-E37E-4442-A2E5-209249DE5480

P478

Q42428990-22F548FE-469F-4A3B-8631-76541C6B966B

P577

Q42428990-848DE5F0-231C-46A5-9480-5A655BD20365

P5875

Q42428990-C38007CF-2FF6-47A3-BA94-5AA91CF80589

P698

Q42428990-5B63F7D0-7383-4F67-B3B2-8758656A71F1

P921

Q42428990-CAF314BD-355D-4B40-A8AA-BBEAC88B1D66

P932

Q42428990-5F1F9F3F-A441-4D5E-BD15-41546058B6ED

P356

P1433

Human Gene Therapy

P1476

Magnetic resonance imaging-gui ...... f lysosomal storage disorders.

@en

P2093

A P Kells

http://www.w3.org/2001/XMLSchema#string

E Aguilar Salegio

http://www.w3.org/2001/XMLSchema#string

J Bringas

http://www.w3.org/2001/XMLSchema#string

J Forsayeth

http://www.w3.org/2001/XMLSchema#string

K S Bankiewicz

http://www.w3.org/2001/XMLSchema#string

L S Shihabuddin

http://www.w3.org/2001/XMLSchema#string

M A Passini

http://www.w3.org/2001/XMLSchema#string

M S Fiandaca

http://www.w3.org/2001/XMLSchema#string

P Hadaczek

http://www.w3.org/2001/XMLSchema#string

R M Richardson

http://www.w3.org/2001/XMLSchema#string

P2860

Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.

Controlled dissemination of AAV vectors in the primate brain.

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates

Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.

Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1.

Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease.

Selective and rapid uptake of adeno-associated virus type 2 in brain.

Adeno-associated virus vectors can be efficiently produced without helper virus.

Critical issues in gene therapy for neurologic disease.

P304

1093-1103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/HUM.2010.040

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43245958

http://www.w3.org/2001/XMLSchema#string

P698

20408734

http://www.w3.org/2001/XMLSchema#string

P921

P932

2936496

http://www.w3.org/2001/XMLSchema#string